PDE9-IN-1

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

PDE9-IN-1 是一种有效的、选择性的、口服生物可利用的磷酸二酯酶-9A (PDE9A) 抑制剂（IC50 为 8.7 nM）。

PDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).(In Vivo):In the Unilateral common carotid artery occlusion (UCCAO) mouse model, PDE9-IN-1 (2.5-5.0 mg/kg; orally) significantly reduces the day 6 escape latency time, increases the frequency of platform area crossings, and recoveres learning and memory function. High dose group possibly improved the escape latency time of mice.

PDE9-IN-1 is excellent selectivity across PDE families.

PDE9-IN-1 (2.5 and 5.0 mg/kg; Oral administration; daily for 21 days) effectively recovers learning and memory function. Animal Model:Unilateral common carotid artery occlusion (UCCAO) mouse model Dosage:2.5 and 5.0 mg/kg Administration:Oral administration; daily for 21 days Result:Significantly reduced the day 6 escape latency time and increased the frequency of platform area crossings, and recovered learning and memory function. High dose group possibly improved the escape latency time of mice.

——

Others

Other Targets

NMDA receptor

——

——

2305087-92-5

362.409

C17H23FN6O2

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (275.94 mM)

C[C@@H](Nc1nc2n(ncc2c(=O)[nH]1)C1CCCC1)C(=O)N1CC[C@H](F)C1

——

(-20℃)

With Ice Pack

≥ 2 years